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Abstract 11 
Shati/Nat8L significantly increased in the nucleus accumbens (NAc) of mice after repeated 12 
methamphetamine (METH) treatment. We reported that Shati/Nat8L overexpression in mouse 13 
NAc attenuated METH-induced hyperlocomotion, locomotor sensitization, and conditioned 14 
place preference. We recently found that Shati/Nat8L overexpression in NAc regulates the 15 
dopaminergic neuronal system via the activation of group II mGluRs by elevated N-16 
acetylaspartylglutamate following N-acetylaspartate increase due to the overexpression. These 17 
findings suggest that Shati/Nat8L suppresses METH-induced responses. However, the 18 
mechanism by which METH increases the Shati/Nat8L mRNA expression in NAc is unclear. 19 
To investigate the regulatory mechanism of Shati/Nat8L mRNA expression, we performed a 20 
mouse Shati/Nat8L luciferase assay using PC12 cells. Next, we investigated the response of 21 
METH to Shati/Nat8L expression and CREB activity using mouse brain slices of NAc, METH 22 
administration to mice, and western blotting for CREB activity of specific dopamine receptor 23 
signals in vivo and ex vivo. We found that METH activates CREB binding to the Shati/Nat8L 24 
promoter to induce the Shati/Nat8L mRNA expression. Furthermore, the dopamine D1 25 
receptor antagonist SCH23390, but not the dopamine D2 receptor antagonist sulpiride, 26 
inhibited the upregulation of Shati/Nat8L and CREB activities in the mouse NAc slices. Thus, 27 
the administration of the dopamine D1 receptor agonist SKF38393 increased the Shati/Nat8L 28 
mRNA expression in mouse NAc. These results showed that the Shati/Nat8L mRNA was 29 
increased by METH-induced CREB pathway via dopamine D1 receptor signaling in mouse 30 
NAc. These findings may contribute to development of a clinical tool for METH addiction. 31 
 32 
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Introduction 35 
Addiction and abuse of drugs such as methamphetamine (METH) are social problems 36 
worldwide [1]. It is well-known that METH induces specific behavioral responses such as 37 
hyperlocomotion, locomotor sensitization, and conditioned place preference in mice [2] and 38 
increases dopamine levels in the synaptic clefts [3, 4]. Many psychostimulative properties 39 
induced by METH increase dopamine levels via the inhibition of reuptake through the 40 
dopamine transporter on presynapses in specific regions, including the nucleus accumbens 41 
(NAc) [5]. Projection of the dopaminergic neuronal system from theｌｌ ventral tegmental 42 
area (VTA) to NAc is associated with METH dependence [6]. Medium spiny neurons that 43 
express dopamine D1 or D2 receptors (D1 or D2-MSN) in NAc are GABAergic neurons, and 44 
D1-MSN of NAc projected to VTA and strongly preferred the GABA neurons of VTA [7]. 45 
These reports demonstrated that projection from VTA to NAc is critical for METH addiction 46 
and that D1-MSN at NAc may affect the activity of VTA dopaminergic neurons. 47 
We previously showed that Shati, which is a novel molecule containing a conserved 48 
sequence of the N-acetyltransferase superfamily, was elevated in NAc of mice administered 49 
METH [8]. Ariyannur and coworkers reported that Shati generated N-acetylaspartate (NAA) 50 
from aspartate and acetyl-CoA as N-acetyltransferase 8-like protein (Nat8l) [9]. Next, we 51 
renamed the molecule from Shati to Shati/Nat8L [10-12]. NAA passes through conversion to 52 
N-acetylaspartylglutamate (NAAG) as the agonist of metabotropic glutamate receptor type 3 53 
(mGluR3) [13]. 54 
Knockdown of Shati/Nat8L by the treatment of mice with antisense oligonucleotides 55 
showed that METH-induced behavioral alterations were enhanced and dopamine levels in 56 
NAc were increased [8]. We recently reported that the overexpression of Shati/Nat8L by 57 
adeno-associated virus vector in NAc attenuated METH-induced responses by controlling the 58 
dopaminergic system via the activation of mGluR3 [11]. Furthermore, Shati/Nat8L promoted 59 
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the localization of dopamine D1 receptor to the cell surface via association with the adaptor 60 
protein-2 complex [14]. Thus, the expression of Shati/Nat8L contributes to behaviors 61 
depending on dopaminergic neurons and molecular localizations with dopamine receptors. 62 
These findings indicate that the regulatory system of the expression of Shati/Nat8L in NAc 63 
could be critical for dopamine-induced dependent behaviors. However, the detailed 64 
mechanism of the expression of Shati/Nat8L in the mouse brain is unclear. 65 
In this study, we investigated METH-induced increases in Shati/Nat8L mRNA to 66 
understand the expression mechanism and identified the Shati/Nat8L promoter of the mouse 67 
gene. We found that the transcriptional factors cAMP response element-binding protein 68 
(CREB) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) may 69 
bind to the promoter region of Shati/Nat8L and that the induction of the Shati/Nat8L mRNA 70 
expression is regulated by CREB via the activation of dopamine D1 receptors; furthermore, 71 
we discussed about how a clarification of the regulatory mechanism of Shati/Nat8L may 72 
contribute to the development of a clinical tool for METH addiction.  73 
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Materials and Methods 74 
Drugs and Reagents 75 
METH hydrochloride was purchased from Dainippon Sumitomo Pharmaceutical Co. (Osaka, 76 
Japan). SKF38393 hydrobromide, quinpirole hydrochloride, and sulpiride were purchased 77 
from Tocris Bioscience (Bristol, UK). SCH23390 hydrochloride was acquired from Sigma-78 
Aldrich (St. Louis, MO). The doses of these drugs were the same as those used in previous 79 
studies SKF38393 (0.5 mg/kg) [14], quinpirole hydrochloride (0.05 mg/kg, 0.5 mg/kg), 80 
SCH23390 hydrochloride (0.5 mg/kg) [15, 16], and sulpiride (20 mg/kg) [17]. 81 
Animals 82 
Male C57BL/6J inbred mice were acquired from Nihon SLC Inc. Japan (Shizuoka, Japan) 83 
were 8 weeks old. Mice and kept in the animal institute of University of Toyama were in a 84 
temperature- and humidity-controlled environment under a 12-h light/12-h dark cycle (lights 85 
on at 8:00) and had ad libitum access to food and water.  The health and welfare of the animals 86 
was monitored by staff at least once a day.  All mice were quickly decapitated by animal 87 
guillotine without feeling any suffering, since the fresh brain tissues were needed for the 88 
isolation of mRNA or brain slices. This procedure were done without anesthesia to avoid the 89 
effect of anesthetic drugs. All procedures followed the National Institute of Health Guideline 90 
for the Care and Use of Laboratory Animals (NIH publication No. 85–23, revised in 1996) 91 
and were approved by the committee for Animal Experiments of the University of Toyama 92 
(Permit Number A2015-PHA23). In the permission, It has been stated that even during the 93 
experiment period,  if an animal experiences symptoms of torture (self-injury behavior, 94 
abnormal posture, crying etc.) and rapid weight loss (more than 20% in several days), take 95 
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measures of euthanasia, with sodium pentobarbital (120mg/kg).  However no mice were 96 
observed in such a situation in this study. 97 
 98 
Cell Culture 99 
Rat PC12 cells were obtained from RIKEN (Ibaraki, Japan) and used within 12 passages of 100 
the original vial. PC12 cells were grown in high–glucose Dulbecco’s eagle medium (D-101 
MEM) (Wako Pure Chemicals, Osaka, Japan) supplemented with 10% fetal bovine serum 102 
(FBS) (Nichirei Biosciences, Tokyo, Japan), 5% horse serum (Gibco BRL, Palo Alto, CA), 103 
and 1% penicillin/streptomycin (PS). Mouse neuroblastoma-cells (Neuro2a) were obtained 104 
from DS Pharma Biomedical (Osaka, Japan) and within 12 passages of the original vial. 105 
Neuro2a cells were grown in D-MEM (low glucose) (Wako Pure Chemicals) supplemented 106 
with 10% FBS and 1% PS. Cell cultures were all maintained at 37°C in a humidified 107 
atmosphere containing 5% CO2. 108 
Quantitative RT-PCR 109 
Quantitative RT-PCR for Shati/Nat8L was performed according to a method previously 110 
reported [14]. In brief, total RNA extraction was performed using TRIsure (Meridian Life 111 
Science Company, Memphis, TN). Total RNA extracted from NAc tissue of mice, PC12 cells, 112 
and Neuro2a were transcribed into cDNA using the Prime Script RT reagent kit (Takara, Shiga, 113 
Japan) according to the manufacturer’s instructions. The reaction was performed at 37°C for 114 
20 min in a total volume of 10 µl and inactivated at 85°C for 10 s. Real-time PCR was 115 
performed using SYBR-Green-based reagents (Thunder Bird Sybr qPCR Mix, Toyobo, Tokyo, 116 
Japan) and a Takara Dice Real Time System (Takara). The reaction was performed according 117 
to the cycling protocol (5 min heat activation of the enzyme at 95°C, 40 cycles of denaturation 118 
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at 95°C for 20 s, annealing at 60°C for 20 s, and extension at 72°C for 20 s). The following 119 
primer sequences were used for PCR: 5′-GTGATTCTGGCCTACCTGGA-3′ (forward) and 120 
5′-CCACTGTGTTGTCCTCCTCA-3′ (reverse) as mice Shati/Nat8L primers for mice brain 121 
tissue and Neuro2a, 5′-GTGATTCTGGCCTACCTGGA-3′ (forward) and 5′-122 
CCACTGTGTTGTCTTCCTCA-3′ (reverse) as Rattus Shati/Nat8L primers for PC12 cells, 123 
5′-ACCCTGAAGTGCTCGACATC-3′ (forward,) and 5′-AGGAAGGCCTTGACCTTTTC-124 
3′ (reverse) as mice 36B4 primers and 5′-CTCAGTGCCTCACTCCATCA-3′ (forward) and 125 
5′-CTTCCTTTGCTTCGACCTTG-3′ (reverse) as Rattus 36B4 primers for PC12 cells. 126 
Design and Production of Vectors 127 
Production of Shati/Nat8L luciferase vector was performed according to a method previously 128 
reported [18].To perform the luciferase assay, we produced Shati/Nat8L promoter-driven 129 
luciferase vectors from the pGL3-Basic Vector (Promega, Madison, WI) after in silico analysis 130 
on TF search: Searching Transcription Factor-Binding Sites (ver 1.3: 131 
http://diyhpl.us/~bryan/irc/protocol-online/protocol-cache/TFSEARCH.html). Because we 132 
found putative binding sites of major transcriptional factors, specifically, AP-1, NF-B, and 133 
CREB, by in silico analysis of TF search in the Shati/Nat8L promoter, we produced various 134 
expression vectors that subsequently had their Shati/Nat8L promoter region deleted. 135 
Shati/Nat8L promoter fragments with different lengths of –980/+120, –680/+120, –380/+120, 136 
–270/+120, and – 150/+120 were prepared from C57BL/6J brain cDNA. Each promoter 137 
fragment was produced by PCR (5 min of heat activation of the enzyme at 94°C, 40 cycles of 138 
denaturation at 95°C for 30 s, annealing at 58°C for 1 min, and extension at 72°C for 1 min) 139 
using the following primers: 5′-GAGCTCTATAGGAGGACCGGGGCAATG-3′ as –140 
980/+120 upstream primer, 5′-GAGCTCGGCCCTTCTGCCTGACTGTCCTC-3′ as –141 
680/+120 upstream primer, 5′-GAGCTCATTACCCTACTCCCAGGTTCC-3′ as –380/+120 142 
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upstream primer, 5′-GAGCTCCCGTTCTGCTGGCTCC-3′ as –270/+120 upstream primer, 5′-143 
GGTACCGGATATGCCACTACGCATTCC-3′ as –150/+120 upstream primer, and 5′-144 
CTCGAGGATGCACGCGCTGCCTGACAG-3′ as +120 downstream primer. The PCR-145 
amplified DNA products were cloned into the pGL3-Basic Vector (Promega, Madison, WI). 146 
The 5′ end of forward primers were linked enzyme sequence of Sac1 or Kpn1, whereas the 147 
reverse primer was linked to Xho1. The 1100-, 800-, 500-, 390-, and 270-bp bands were 148 
produced by agarose gel electrophoresis. The products were digested with these linked 149 
restriction enzymes and directly ligated to the pGL3-Basic Vector. Expression vectors for 150 
dopamine receptor D1A (drd1a) and dopamine receptor D2 (drd2) were produced by ligation 151 
to pcDNA 3.1v5-His B (Thermo Fisher Scientific, MA), such as using pGL3-Basic Vector 152 
and the following primers: 5′-GGTACCGGAAGATGGCTCCTAAC-3′ as drd1a forward 153 
primer (linked 5-Kpn1), 5′-TCTAGACCAATATTCAGGTTGAATGCTG-3′ as drd1a 154 
reverse primer (linked 5 -Xba1), 5′-AAGCTTCCCAATGGATCCACTGAACC-3′ as drd2 155 
forward primer (linked 5 -Hind3) and 5′-GATATCGACTCAGCAGTGCAGGATC-3′ as 156 
drd2 reverse primer (linked 5 -EcoR5). 157 
Transfection and Dual Luciferase Assay 158 
Dual luciferase assay was performed according to a method previously reported [18]. pGL3-159 
Basic vector containing Shati/Nat8L promoter was transfected into PC12 cells using 160 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s 161 
recommendations. In brief, cells were incubated to confluency in 24-well plates for 24 h and 162 
exposed to a mixture of 2 µl/well of lipofectamine 2000 and 0.8 µg/well of plasmid DNA 163 
(Shati/Nat8L promoter-driven pGL3-Basic Vector 0.5 µg/well and CMV-Renilla luciferase 164 
0.3 g/well). Twenty-four hours after the transfections, the cells were incubated in a medium 165 
containing phosphate-buffered saline or METH (1 M) for 2 h. The mediums were changed 166 
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to the normal one, and then the cells were incubated for 22 h. A reporter assay was performed 167 
using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI) following the 168 
instructions in the manual. The activity of CREB and NF-B were determined same protocol 169 
as Shati/Nat8L promoter’s one using CRE-luc and B-luc vectors instead of  Shati/Nat8L 170 
vector. 171 
Chromatin Immunoprecipitation Assay 172 
Chromatin immunoprecipitation (ChIP) was performed with mice NAc fixed by 3.7% 173 
paraformaldehyde solution for 15 min at room temperature, then resuspended in 200 µl of 1% 174 
sodium dodecyl sulfate (SDS) lysis buffers, 10 mM EDTA pH 8.0, 50 mM Tris–HCl pH 8.1 175 
(Wako Pure Chemicals), 1 mM phenylmethylsulfonyl fluoride (Wako Pure Chemicals), and 176 
2% protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan) and then sonicated to solubilize 177 
and shear crosslinked DNA. The suspension was centrifuged (20,000g, 4°C, 10 min), and then 178 
the supernatant was collected; 900 µl of ChIP dilution buffer (0.01% SDS, 1.1% TritonX-100, 179 
1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl, 1 mM phenylmethylsulfonyl fluride 180 
(PMSF), 2% protease inhibitor cocktail) was then added to 100 µl of supernatant. The 181 
productions were incubated overnight at 4°C with 75l of Protein G Sepharose (GE Healthcare, 182 
Tokyo, Japan) that had been preincubated with 3 g of the appropriate antibodies {normal rabbit 183 
immunoglobulin G (IgG), CREB (48H2) rabbit mAb and NF-B p65 (D14E12) XP Rabbit} 184 
(Cell Signaling Technology). Protein G sepharose was washed five times with low-salt buffer 185 
(0.1% SDS, 1% TritonX-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 150 mM NaCl), high-186 
salt buffer (0.1% SDS, 1% TritonX-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 500 mM 187 
NaCl), LiCl buffer (120 mM LiCl, 0.5% NP40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-188 
HCl pH 8.1) and twice washed with Tris-EDTA buffer (10 mM Tris-HCl pH 8.1, 1 mM EDTA). 189 
Furthermore, we extracted crosslinked DNA with 500 µl of elution buffer (10 mM dithiothreitol, 190 
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1% SDS, 0.1M NaHCO3) containing 50 mM NaCl. Bound complexes were eluted from the 191 
beads by heating at 65°C for 8 h. These elution buffers were incubated with 20 µg/ml of 192 
proteinase K (Wako, Osaka, Japan) for 2 h. Extracted DNA was then purified by 193 
phenol/chloroform/isopropanol. Purified DNA samples were normalized to 500 ng/10 µl and 194 
subjected to PCR analysis. The PCR primers were 5′-195 
CTCGAGCCATTGTTGGAGCCAGCAGAACGG-3′ as the –270 downstream primer, and 196 
the others were the same primers as used in the luciferase assay. We analyzed PCR products by 197 
electrophoresis using 1.5% agarose gels and normalized the fluorescence of ethidium bromide 198 
to that of the control IgG. 199 
Western Blotting 200 
Mice were decapitated 2 h after the last METH-treatment (2 mg/kg, 6 days), and a NAc fraction 201 
was taken by brain slice. In the brain slice experiments, we also took the slices immediately 202 
after drug stimulations [artificial cerebrospinal fluid (aCSF) or METH]. NAc tissues were 203 
added to RIPA buffer (50 mM Tris-HCl pH 7.5, 152 mM NaCl, 5 mM EDTA, 1% TritonX-204 
100, 0.5% sodium deoxy cholate, 1 mM PMSF, 2% protease inhibitor cocktail, 1% phosphatase 205 
inhibitor cocktail), sonicated on ice, and then centrifuged at 20,000g for 15 min at 4°C. A 206 
volume of sample buffer (312.5 mM Tris-HCl, 25% 2-mercaptoethanol, 10% SDS, 25% 207 
sucrose, 0.025% bromophenol blue) five times the supernatant volume was added. The mixture 208 
was then altered by thermal denaturation at 95°C for 5 min. The target proteins were isolated 209 
using a SDS-polyacrylamide gel electrophoresis (PAGE) method and removed from the 210 
polyacrylamide gel to a polyvinylidene fluoride membrane (Immobilon-P Trans Membrane, 211 
Merck Millipore, Darmstadt, Germany) using a semi-dry transfer method. The blots were 212 
blocked for 1 h at room temperature using 5% skim milk in Tris-buffered saline solution 213 
containing 0.1% Tween-20 (TBS-T). The membranes were incubated with polyclonal 214 
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antibodies (CREB 48H2 Rabbit mAb, phospho-CREB Ser133, or 87G3 Rabbit mAb; Cell 215 
Signaling Technology) and diluted 1:1,000 in TBS-T containing 2% skim milk at 4°C for 16 h. 216 
The blots were then washed and incubated with the secondary antibody, horseradish peroxidase 217 
(HRP)-linked goat-rabbit IgG (Cell Signaling Technology). The HRP was detected using an 218 
Amersham ECL Plus Western Blotting Reagent Pack (GE Healthcare). 219 
Experiments Using Mouse Brains 220 
Brain slice experiments were performed following the protocol provided with the ChIP assay 221 
kit as described previously [19]. C57BL/6J mice were quickly decapitated, and their brains 222 
were removed and placed into ice-cold aCSF saturated with oxygen (95% O2–5% CO2 223 
mixture, pH 7.4). Coronal mice brains were cut (400 µm) in iced aCSF and transferred to a 224 
recovery chamber containing  aCSF for 50 min at room temperature. Brain slices were 225 
stimulated with METH (100 µM or 1 mM) or aCSF for 1 h after the stimulation of aCSF, 226 
PKA inhibitor KT5720 (3M), dopamine D1 receptor antagonist SCH23390 (10 µM) or 227 
dopamine D2 receptor antagonist sulpiride (10 µM) in aCSF for 30 min, and then NAc tissues 228 
were taken for measurement of Shati/Nat8L mRNA. The accurate location of NAc structure 229 
was based on visual inspection of each section using a stereomicroscope and compared with 230 
the stereotaxic atlas of mouse brain [20]. NAc structures were placed on dry ice and stored at 231 
–80°C until use. 232 
Statistical Analysis 233 
All data were expressed as the mean ±SEM. Statistical differences between the two groups 234 
were determined using Student’s t-test. Statistically significant differences among values 235 
for individual groups were determined by analysis of variance, followed by the Student– 236 
Newmann–Keuls post hoc test when F ratios were significant (p < 0.05). 237 
238 
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Results 239 
Shati/Nat8L mRNA was Increased by METH Treatment in NAc 240 
and PC12 Cells 241 
Repeated administrations of METH (2 mg/kg for 6 days, s.c.) to C57BL/6J mice 242 
significantly induced Shati/Nat8L mRNA in NAc (n = 4, Fig. 1A, t13 = 2.8793). METH (1 243 
µM) also potentiated Shati/Nat8L expression 2 h after the stimulation of PC12 cells (n = 4, 244 
Fig. 1B, t13 = 3.5731) but not Neuro2a cells (n = 4, Fig. 1C). These results were consistent 245 
with those of our previous report [8, 21], which indicated that PC12 cells could upregulate 246 
Shati/Nat8L treated with METH. Therefore, PC12 cells were used for the luciferase assay in 247 
this study to clarify the regulatory system of Shati/Nat8L production. 248 
 249 
Figure 1. Effects of methamphetamine (METH) on Shati/Nat8L mRNA in the nucleus 250 
accumbens (NAc) of mice and cultured cells.  251 
(A) Shati/Nat8L mRNA levels in NAc of mice repeatedly administered saline or METH (2 252 
mg/kg/day) for 6 days. NAc samples taken 2 h after the last treatment.  n = 4. *p < 0.05 vs 253 
saline group (Student’s t-test). Increasing levels of Shati/Nat8L mRNA induced by METH (1 254 
µM) in (B) PC12 (B) and (C) Neuro2a cells. These cells were exposed to METH for 2 h. 255 
After the procedure, samples were taken for measurement of Shati/Nat8L mRNA **p < 0.001 256 
vs PBS group (Student’s t-test). n = 4. .Error bars represent the SEM. 257 
 258 
CREB and NF-B -Binding Regions of Shati/Nat8L Promoter 259 
were Necessary for METH-induced Potentiation in PC12 Cells 260 
13 
 
Because PC12 cells have dopamine transporters and tyrosine hydroxylase, the cells are 261 
useful as a model of the neuronal system [21]. Thus, the cells were used for investigation of the 262 
Shati/Nat8L productive system (Fig. 1B). By in silico analysis on TF search, the putative binding 263 
sites of major transcriptional factors, specifically, AP-1, NF-B, and CREB, were identified in 264 
the Shati/Nat8L promoter region. We designed a pGl3-Basic Vector driven by Shati/Nat8L 265 
promoter in which these binding sites were subsequently deleted. Luciferase activities were 266 
increased by METH on −980/+120 bp (3.16 ± 0.16-folds), −680/+120 (3.29 ± 0.66-folds) and –267 
380/+120 (2.63 ± 0.11-folds).  Promoter region of -380/+120 was decreased compared with 268 
those of -980/+120 and -680/+120. We found no activity on –270/+120 (1.09 ± 0.11-folds) and 269 
−150/+120 (1.09 ± 0.07-folds) vector 22 h after METH stimulation for 2 h (Fig. 2A: −980/+120 270 
vs −380/+120; F4.15 = 4.474, −980/+120 vs −270/+120; F4.15 = 15.88, −980/+120 vs 271 
−150/+120; F4.15 = 15.84, −680/+120 vs −380/+120; F4.15 = 4.461, −680/+120 vs 272 
−270/+120; F4.15 = 15.87, −680/+120 vs −150/+120; F4.15 = 150.83, −380/+120 273 
vs −270/+120; F4.15 = 11.41, −380/+120 vs −150/+120; F4.15 = 11.36). The two 274 
transcriptional factors, CREB and NF-B, were bound to the promoter region of 275 
Shati/Nat8L using the luciferase assay. Moreover, METH induced luciferase activities of 276 
CREB and NF-B using CRE-luc and κB-luc vectors (CRE-luc; 1.75 ± 0.25-folds and B-277 
luc; 1.48 ± 0.032-folds) in PC12 cells (Fig. 2B). These results suggested that METH 278 
activates CREB and NF-B, which then induce Shati/Nat8L in PC12 cells. 279 
 280 
Figure 2. Luciferase assay using various fragments of Shati/Nat8L promoter regions in 281 
PC12 cells. 282 
 (A)  PC12 cells transfected with PGl3-Basic Vector containing five kinds of promoter region 283 
for the luciferase assay. Detection of luciferase 22 h after 2 h-methamphetamine (METH) 284 
stimulation using a Dual Luciferase Assay kit. ##p < 0.05 and ###p < 0.001 vs luciferase activities 285 
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on PC12 cells comparing with −980 bp and −680 bp vector (Newman–Keuls post hoc test). n 286 
= 4. (B) METH induces activities of transcriptional factors in PC12 cells treated with METH.*p 287 
< 0.05 and **p < 0.01 vs PBS (Student’s t-test). n = 4. Error bars represent the SEM. 288 
METH Induced CREB, but not NF-B, Bind to the Shati/Nat8L 289 
Promoter in NAc of Mice 290 
 A ChIP assay was performed on NAc tissue to identify transcriptional factors that 291 
increased Shati/Nat8L in response to METH. The assay showed that CREB and NF-B were 292 
bound to the promoter of Shati/Nat8L. The luciferase assay was then performed (Fig. 3A). 293 
However, METH induced binding of CREB but not of NF-B to the promotor (n =9, Fig. 3A 294 
and B: saline/control IgG vs saline/anti-CREB, F3.32 = 18.63; METH/control IgG vs 295 
METH/anti-CREB, F3.32 = 28.51; saline/anti-CREB vs METH/anti-CREB, F3.32 = 9.961). In 296 
NAc of mice administered METH for 6 days, activation of CREB was observed (Fig. 3A and 297 
B). Thus, repeated METH treatment of mice potentiated the phosphorylation of CREB in 298 
NAc (Fig. 3C). These results suggest that METH facilitates CREB binding to the Shati/Nat8L 299 
promoter region from −380 bp to −270 bp. 300 
 301 
Figure 3. cAMP response element-binding protein (CREB) binding to Shati/Nat8L 302 
promoter was activated by administration of methamphetamine (METH).  303 
(A and B) ChIP (chromatin immunoprecipitation) assay was performed with antibodies for 304 
CREB and NF-B on the nucleus accumbens (NAc) of mice repeatedly administered METH 305 
(2 mg/kg/day for 6 days. s.c.) For each group. ***p < 0.0001 vs control IgG (-380~-270), $$$p 306 
< 0.0001 vs saline, ###p < 0.0001 vs control IgG (-680~-270) (Newman–Keuls post hoc test). 307 
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n = 9 (C) Repeated METH potentiated the immunoreactivity of p-CREB/CREB in NAc. *p 308 
< 0.05 vs  saline group (Student’s t-test). n = 6. Error bars represent the SEM. 309 
 310 
Increased cAMP by Forskolin Potentiated Shati/Nat8L 311 
Expression in PC12 Cells and Brain Slices 312 
The ChIP assay results showed that CREB was necessary for potentiation of Shati/Nat8L 313 
expression. To investigate the upstream of CREB in the Shati/Nat8L site, we focused on cAMP, 314 
which activates PKA following CREB activity. Stimulation of forskolin (10 µM), an inducer for 315 
cAMP signaling, increased Shati/Nat8L mRNA in PC12 cells (Fig. 4A). Moreover, the 316 
luciferase assay results supported the possibility that CREB induced Shati/Nat8l expression in 317 
PC12 cells (Fig. 4B).   Furthermore, stimulation of KT5720 (3 µM) were significantly inhibited 318 
the expression of Shati/Nat8L mRNA expression induced by METH in mice brain slices (Fig. 319 
4C: aCSF vs METH, F3.20 = 4.233; METH vs METH+KT5720, F3.20 = 4.553). These results 320 
suggested that CREB activity for Shati/Nat8L expression is caused by cAMP increases. 321 
 322 
Figure 4. The Effects of cAMP on Shati/Nat8L mRNA expression in PC12 cells and the 323 
nucleus accumbens slice.  324 
(A) PC12 cells treated with forskolin (10 µM) or DMSO as control for 2 h to perform qPCR.  325 
***p < 0.0001 vs DMSO (Student’s t-test). (n=4)(B) PC12 cells were transfected with PGl3-326 
Basic Vector, including five kinds of promoter for Shati/Nat8L using luciferase assay. 327 
Detection of luciferase performed 22 h after 2-h forskolin stimulation (10 µM) using a Dual 328 
Luciferase Assay kit.  ##p < 0.001 vs –980/+120, −680/+120, and −380/+120 vector (Newman–329 
Keuls post hoc test). (n=4) (C) Brain slices treated with a PKA inhibitor, KT5720 (3 µM), for 330 
30 min before methamphetamine (METH) treatment (1 mM) to perform qPCR. *p < 0.05 vs 331 
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aCSF, #p < 0.05 vs METH (Newman–Keuls post hoc test). (n=4-8) Error bars represent the 332 
SEM. 333 
Shati/Nat8L mRNA Expression was Increased by METH via 334 
Dopamine D1 Receptor Signaling to CREB 335 
To examine the upstream of METH-induced CREB activity, experiments involving 336 
pharmacological inhibition of METH activity were performed. Because it is well known that 337 
METH increases dopamine levels [3, 4], we focused on dopamine receptor signals. 338 
Pretreatment with SCH23390 (0.5 mg/kg s.c.), but not sulpiride (20 mg/kg s.c.), inhibited 339 
METH-induced increases in Shati/Nat8L mRNA in NAc (Fig. 5A: saline vs METH, F3.15 = 340 
4.483; saline vs sulpiride + METH, F3.15 = 3.074; METH vs SCH23390+METH, F3.15 = 3.706). 341 
In addition, dopamine D1 receptor antagonist inhibited METH-induced CREB activity in 342 
NAc (Fig. 5B: saline vs METH; F3.16 = 5.021, saline vs sulpiride + METH F3.16 = 4.386, 343 
METH vs SCH23390+METH F3.16 = 6.852). To determine the degree that dopamine D1 or 344 
D2 receptors contributed to the METH-related activity,   we injected D1 receptor agonist or 345 
D2 receptor agonist into mice (s.c.). Thus, single- or repeated dopamine D1 receptor agonist 346 
SKF38393 (0.5 mg/kg, s.c.) administration potentiated Shati/Nat8L mRNA expression in 347 
NAc of mice (Fig. 5C and D). However, dopamine D2 agonist quinpirole hydrochloride had 348 
no effects on Shati/Nat8L mRNA expression in NAc (Fig. 5E and F). Alternatively in PC12 349 
cells SCH23390, but not sulpiride,   inhibited the increase in Shati/Nat8L mRNA (Fig. 5G: 350 
PBS vs METH; F3.12 = 6.291, PBS vs sulpiride + METH; F3.12 = 5.734, METH vs 351 
SCH23390+METH; F3.12 = 5.554). These results supported a putative mechanism in which 352 
Shati/Nat8L expression is regulated by activation of dopamine D1 receptor signaling. 353 
 354 
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Figure 5. Dopamine D1 receptor potentiated expression of Shati/Nat8L mRNA by 355 
methamphetamine (METH) in the nucleus accumbens (NAc). 356 
(A) The effects of pharmacological inhibition by dopamine D1 (SCH23390, 0.5 mg/kg) or D2 357 
(sulpiride, 20 mg/kg) receptor antagonist in mice NAc were analyzed by qPCR.  Dopamine 358 
D1 receptor antagonist inhibits METH-induced increases in Shati/Nat8L mRNA in NAc. *p < 359 
0.05 vs saline, ##p < 0.01 vs METH effects (Newman–Keuls post hoc test). n=4-5.  (B) 360 
Phosphorylation of cAMP response element-binding protein (CREB) in mice NAc were 361 
assayed by Western blotting. **p < 0.01 vs saline, #p < 0.005 vs METH effects (Newman–362 
Keuls post hoc test) n=5.  The effects of Shati/Nat8L mRNA in mice NAc by  (C)  single and  363 
(D) repeated administrations of dopamine D1 receptor agonist, SKF38393 (0.5 mg/kg s.c.) 364 
were analyzed by real time RT-PCR. *p < 0.05 and **p < 0.01 vs saline in each condition 365 
(Student’s -t-test). n=4. The influences of (E) single (n=4) and (F) repeated administration of 366 
dopamine D2 agonist quinpirole hydrochloride (Quin) (0.05 and 0.5 mg/kg s.c.) assayed by 367 
qPCR. n=5.  (G) Dopamine D1 or D2 receptor antagonist (D1: SCH23390 10M, D2: sulpiride 368 
10M) were pretreated before METH (1mM) stimulation in PC12 cells, followed by qPCR for 369 
Shati/Nat8L mRNA expression was determined. **p < 0.01 vs PBS, ##p < 0.05 vs METH effects 370 
(Newman–Keuls post hoc test). n=4.  Error bars represent the SEM.  371 
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Discussion 372 
Shati/Nat8L has been shown to be increased in NAc of mice after repeated treatment of 373 
METH [8]. Important neuronal roles of Shati/Nat8L, in addition to the function of lipid 374 
turnover in brown adipocytes, were subsequently demonstrated [11, 12, 14, 22, 23]. Recently, 375 
it was reported that NAA produced from Shati/Nat8L was associated with Canavan disease 376 
[24]. Although these reports have shown that Shati/Nat8L has important physiological 377 
functions in the central nervous system and peripheral tissues, the regulatory mechanism of 378 
Shati/Nat8L expression has remained unknown. In the present study, we attempted to 379 
elucidate the mechanism of Shati/Nat8L production at the molecular level. 380 
First, we reconfirmed the activation of Shati/Nat8L mRNA expression in NAc of mice 381 
repeatedly treated with METH (Fig. 1A). This finding of inductive activity agreed with our 382 
previously reported findings [8]. We also demonstrated that the increase in Shati/Nat8L 383 
mRNA by METH was regulated by CREB activity via dopamine D1 receptor signaling in 384 
NAc of mice (Figs. 3–5). Because PC12 cells have DAT, Tyrosine hydroxylase, and 385 
dopamine receptors, the cells mimicked NAc of mice [7]. Moreover, forskolin, an inducer of 386 
cAMP in cells, also mimicked METH-induced luciferase activity and Shati/Nat8L mRNA 387 
induction (Fig. 4). These results indicated that Shati/Nat8L expression depended on the 388 
CREB and cAMP pathway. Shati/Nat8L mRNA was not increased by treatment with METH 389 
at Neuro2a (Fig. 1B) because Neuro2a has not been considered to have tyrosine hydroxylase 390 
and D1R [25, 26]. Furthermore, overexpression of the drd1a gene, but not the drd2 gene, in 391 
Neuro2a induced Shati/Nat8L mRNA (supplemental figure 1). These results also support our 392 
conclusion that Shati/Nat8L production is dependent on the dopamine D1 receptor pathway. 393 
We have previously reported that Shati/Nat8L overexpression in NAc controlled the 394 
dopaminergic system via activation of mGluR3 by elevated NAAG following NAA production 395 
[11]. We had thought that overexpression of Shati/Nat8L in Nac interneurons indirectly affected 396 
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sensitization to METH and dopamine release to NAc. Nevertheless, a previous report indicated 397 
that METH-induced Shati/Nat8L potentiation occurred at D1-MSN, which directly released 398 
GABA to the GABA interneurons of VTA [7]. Thus, D1R-signal-potentiated NAAG appeared 399 
to suppress GABA release from D1-MSN to GABA interneurons in VTA via activation of 400 
mGluR3 at D1-MSN. 401 
Previously, we reported that Shati/Nat8l knockout caused D1R over localization on cell 402 
surfaces in NAc of mice and that the mice exhibited stronger responses to SKF38393 and 403 
METH than did WT mice [14]. Consistent with the present and previous results, overexpression 404 
of dominant negative CREB in D1R-expressed cells has been shown to increase the response 405 
to cocaine [27]. These results support our finding that Shati/Nat8L expression had a suppressive 406 
role in drug addiction downstream of dopamine D1 receptor signaling. Furthermore, these 407 
reports also indicated that Shati/Nat8L expression by CREB on D1R signaling was regulated 408 
via a cycle involving D1R signaling to CREB activity, CREB to Shati/Nat8L expression, and 409 
Shati/Nat8L to D1R localization. 410 
In the present study, we also showed that Shati/Nat8L expression was regulated by NF-B. 411 
Exogenous TNF-alpha in NAc has been shown to attenuate METH-induced addiction [28]. 412 
Previously, we also showed that Shati/Nat8L overexpression in PC12 cells increased TNF-413 
alpha mRNA and also that Shati/Nat8L KO mice had a lower level of LITAF upstream of 414 
TNF-alpha in the brain [10]. The association of NF-B with Shati/Nat8L promotor using 415 
luciferase assay could be a secondary effect (Fig. 2A and B). The finding indicates that the 416 
promoter activity of NF-B were regulated by TNF-alpha due to Shati/Nat8l upregulation 417 
induced by METH stimulation. These results indicated that the Shati/Nat8L gene may be 418 
associated with the cytokine family. 419 
In conclusion, we demonstrated the importance of the Shati/Nat8L promoter region and 420 
of CREB to Shati/Nat8L expression, and that expression of Shati/Nat8L mRNA was regulated 421 
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especially by activation of CREB. These results suggest that inactivation of this mechanism 422 
may be a risk factor of addiction. 423 
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Supplemental Figure 1 
Fig. S1 The relationship of drd1a gene to Shati/Nat8L expression. 
(A) The Figure indicates that the relationship between Shati/Nat8L 
expression and METH effect on brain slice experiments. **p<0.01 vs. aCSF. 
(Newman–Keuls post hoc test).  (B) Dopamine D1 or D2 receptor antagonist (D1: 
SCH23390 10uM, D2: sulpiride 10uM) was pretreated before METH (1mM) 
stimulation for qPCR of Shati/Nat8L mRNA. **p<0.01 and ***p<0.001 vs., 
aCSF## p<0.01 vs .METH. (Newman–Keuls post hoc test). (C) PC12 cells 
transfected with drd1a or drd2 were taken for qPCR 48 after the transfection * 
p<0.05 vs pcDNA (Newman–Keuls post hoc test). Error bars represent the S.E. M 
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